Published online Jun 28, 2023. doi: 10.3748/wjg.v29.i24.3883
Peer-review started: March 25, 2023
First decision: April 21, 2023
Revised: May 11, 2023
Accepted: May 31, 2023
Article in press: May 31, 2023
Published online: June 28, 2023
Processing time: 94 Days and 13.4 Hours
There are more and more studies in the literature concerning endoscopic and surgical resections for organ preservation in early gastrointestinal neoplasms, respecting oncological principles. Lymph node (LN) study with one-step nucleic acid amplification (OSNA) is also the subject of numerous studies.
Organ-sparing endoscopic and imaging techniques do not currently allow for an accurate LN study. Using LN biopsy with rapid intraoperative results during the laparoscopic and endoscopic cooperative approach can add important information.
This article aims to stimulate studies that can add further information on LN status in patients with early gastrointestinal cancer, which, if treated only with endoscopic technique or with modified Laparoscopic and endoscopic cooperative surgery, would have no additional information on LN status beyond radiological ones. However, our study is the first to evaluate the utility of intraoperative OSNA assay in assessing SN in patients with early-stage gastrointestinal cancer undergoing the Non-exposed endoscopic wall-inversion surgery (NEWS).
This pilot study with a literature review is based on data collected prospectively from a database of patients undergoing elective NEWS for early gastrointestinal cancer at St. Giuseppe Moscati Hospital of Avellino, Italy. The database included preoperative, operative, and postoperative data. Inclusion criteria included adult patients with early gastric and colonic cancer eligible for the NEWS procedure. Exclusion criteria included participants with an allergy to any indocyanine green (ICG).
A total of 10 patients were enrolled in this study, which included 5 gastric and 5 colonic early-stage cancers. The NEWS procedure was successful in all cases. The OSNA assay revealed no LN metastasis in all patients. The diagnostic accuracy in predicting the LN status based on the SN concept by OSNA compared with the postoperative histological examination was 100%. Histologically complete resection (R0) was achieved in 9 (90.0%) patients. There was no recurrence during the follow-up. An intrabdominal fluid collection treated conservatively was observed in 1 (10.0%) patient of the gastric group. One patient who underwent the removal of a lesion affecting the proximal transverse colon presented positive focal margins on a definitive histological examination. Therefore he subsequently underwent a right hemicolectomy. The definitive histological examination showed no residual tumour foci or LN metastases.The mean follow-up was 6.3 ± 4.2 mo. There was no recurrence during the follow-up period. Ours is a single-centre pilot study. The number of patients collected is small. The selected patients were all patients without LN metastasis; therefore, it is not possible to validate the sentinel node technique.
Our study is the first to analyze the utility of intraoperative OSNA assay in sentinel node and nodal basin assessment in patients with early-stage gastrointestinal cancer undergoing the NEWS procedure. NEWS is a feasible and safe technique for organ-sparing surgery in selected patients. Additionally, implementing the NEWS association with the intraoperative study with OSNA will allow for more precise staging.
OSNA and ICG near-infrared lymphangiography could be used to develop customized surgery and lymphadenectomy in patients with early cancers. Prospective multicenter studies with large populations of patient cohorts are needed to provide definitive conclusions.